These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22294124)

  • 21. Histamine H3 receptor antagonists ameliorate attention deficit/hyperactivity disorder-like behavioral changes caused by neonatal habenula lesion.
    Kim YJ; Goto Y; Lee YA
    Behav Pharmacol; 2018 Feb; 29(1):71-78. PubMed ID: 28863002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
    Kantak KM; Singh T; Kerstetter KA; Dembro KA; Mutebi MM; Harvey RC; Deschepper CF; Dwoskin LP
    Behav Neurosci; 2008 Apr; 122(2):340-57. PubMed ID: 18410173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rodent models of attention-deficit/hyperactivity disorder.
    Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M
    Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response acquisition with delayed reinforcement in a rodent model of attention-deficit/hyperactivity disorder (ADHD).
    Hand DJ; Fox AT; Reilly MP
    Behav Brain Res; 2006 Dec; 175(2):337-42. PubMed ID: 17034874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental enrichment improves cognitive deficits in Spontaneously Hypertensive Rats (SHR): relevance for Attention Deficit/Hyperactivity Disorder (ADHD).
    Pamplona FA; Pandolfo P; Savoldi R; Prediger RD; Takahashi RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1153-60. PubMed ID: 19549550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5,7-Dihydroxy-6-methoxy-4'-phenoxyflavone, a derivative of oroxylin A improves attention-deficit/hyperactivity disorder (ADHD)-like behaviors in spontaneously hypertensive rats.
    dela Peña IC; Young Yoon S; Kim Y; Park H; Man Kim K; Hoon Ryu J; Young Shin C; Hoon Cheong J
    Eur J Pharmacol; 2013 Sep; 715(1-3):337-44. PubMed ID: 23707903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
    Dela Peña I; Kim BN; Han DH; Kim Y; Cheong JH
    Arch Pharm Res; 2013 Apr; 36(4):400-10. PubMed ID: 23471559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment.
    dela Peña I; Lee JC; Lee HL; Woo TS; Lee HC; Sohn AR; Cheong JH
    Neurosci Lett; 2012 Apr; 514(2):189-93. PubMed ID: 22414863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impulsivity and sensitivity to amount and delay of reinforcement in an animal model of ADHD.
    Orduña V
    Behav Brain Res; 2015 Nov; 294():62-71. PubMed ID: 26225844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling Symptoms of Attention-Deficit Hyperactivity Disorder in a Rat Model of Fetal Alcohol Syndrome.
    Atalar EG; Uzbay T; Karakaş S
    Alcohol Alcohol; 2016 Nov; 51(6):684-690. PubMed ID: 27117236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABT-724 alleviated hyperactivity and spatial learning impairment in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
    Yin P; Cao AH; Yu L; Guo LJ; Sun RP; Lei GF
    Neurosci Lett; 2014 Sep; 580():142-6. PubMed ID: 25128216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for reduced tonic levels of GABA in the hippocampus of an animal model of ADHD, the spontaneously hypertensive rat.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2013 Dec; 1541():52-60. PubMed ID: 24161405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD).
    Sagvolden T
    Neurosci Biobehav Rev; 2000 Jan; 24(1):31-9. PubMed ID: 10654658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Region-specific elevation of D₁ receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit/hyperactivity disorder.
    Ohno Y; Okano M; Masui A; Imaki J; Egawa M; Yoshihara C; Tatara A; Mizuguchi Y; Sasa M; Shimizu S
    Neuropharmacology; 2012 Sep; 63(4):547-54. PubMed ID: 22580374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.
    Esbenshade TA; Browman KE; Miller TR; Krueger KM; Komater-Roderwald V; Zhang M; Fox GB; Rueter L; Robb HM; Radek RJ; Drescher KU; Fey TA; Bitner RS; Marsh K; Polakowski JS; Zhao C; Cowart MD; Hancock AA; Sullivan JP; Brioni JD
    J Pharmacol Exp Ther; 2012 Oct; 343(1):233-45. PubMed ID: 22815533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problems with spontaneously hypertensive rats (SHR) as a model of attention-deficit/hyperactivity disorder (AD/HD).
    Alsop B
    J Neurosci Methods; 2007 May; 162(1-2):42-8. PubMed ID: 17241669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder.
    Hiraide S; Ueno K; Yamaguchi T; Matsumoto M; Yanagawa Y; Yoshioka M; Togashi H
    Pharmacol Biochem Behav; 2013 Apr; 105():89-97. PubMed ID: 23380523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.